百亞股份(003006.SZ):公司對2024年外圍市場拓展已做規劃和準備
格隆匯1月22日丨百亞股份(003006.SZ)披露投資者關係活動記錄表顯示,2023年公司把廣東、湖南、河北等省份作為重點區域進行拓展,與部分連鎖系統保持合作,有序拓展經銷渠道,通過組織迭代推動人才建設和儲備,加快全國市場拓展節奏。隨着益生菌等系列產品在電商渠道曝光,產品知名度持續提升,推動了外圍省份業績較快增長。公司對2024年外圍市場拓展已做規劃和準備,對線下經銷和KA渠道都做了佈局,團隊及組織也做了相關準備,2024年計劃將2-3個省份納入重點市場進行開拓,預計外圍省份收入會保持較快增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.